| mTORC1 activity as a determinant of cancer risk--rationalizing thecancer-preventive effects of adiponectin, metformin, rapamycin, and low-proteinvegan diets. | Med Hypotheses | 2011 Oct | 21862237 |
| Insulin-mimetic action of conglutin-γ, a lupin seed protein, in mouse myoblasts. | Nutr Metab Cardiovasc Dis | 2011 Mar | 20089385 |
| Influence of therapy with metformin on the concentration of certain divalentcations in patients with non-insulin-dependent diabetes mellitus. | Biol Trace Elem Res | 2011 Jul | 20567934 |
| Glucose homeostasis in rainbow trout fed a high-carbohydrate diet: metformin and insulin interact in a tissue-dependent manner. | Am J Physiol Regul Integr Comp Physiol | 2011 Jan | 21068202 |
| Pharmacology of GLP-1 agonists: describing the therapeutic potential to patients. | J Am Osteopath Assoc | 2011 Feb | 21389294 |
| Metformin abolishes increased tumor (18)F-2-fluoro-2-deoxy-D-glucose uptakeassociated with a high energy diet. | Cell Cycle | 2011 Aug 15 | 21811094 |
| Rapamycin as an antiaging therapeutic?: targeting mammalian target of rapamycin to treat Hutchinson-Gilford progeria and neurodegenerative diseases. | Rejuvenation Res | 2011 Aug | 21851176 |
| Metformin supplementation and life span in Fischer-344 rats. | J Gerontol A Biol Sci Med Sci | 2010 May | 20304770 |
| Glucose supply and insulin demand dynamics of antidiabetic agents. | J Diabetes Sci Technol | 2010 Mar 1 | 20307399 |
| Adjunct therapy for type 1 diabetes mellitus. | Nat Rev Endocrinol | 2010 Jun | 20404854 |